Condition: Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Biphenotypic Acute Leukemia · Sponsor: St. Petersburg State Pavlov Medical University
The therapy under investigation is the addition of 300 000 IU of vitamin A and 100 000 IU of vitamin D before conditioning. The study will include patients with malignant diseases in hematologic response with indications for allogeneic transplantation with matched related or matched unrelated donor.
This description comes directly from the study's public registry record.
IVAN SERGEEVICH MOISEEV · +78123386265 · moisiv@mail.ru
Irina Сергеевич Bykova · +78123386617 · bmt-director@1spbgmu.ru
Always discuss trial participation with your own doctor first.
| RM Gorbacheva Research Institute | Saint Petersburg, Russia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06508099